Calcium signaling in vascular endothelial cells (ECs) and smooth muscle cells (VSMCs) is essential for the regulation of vascular tone. However, the changes to intracellular Ca concentrations are often influenced by sex differences. Furthermore, a large body of evidence shows that sex hormone imbalance leads to dysregulation of Ca signaling and this is a key factor in the pathogenesis of cardiovascular diseases. In this review, the effects of estrogens and androgens on vascular calcium-handling proteins are discussed, with emphasis on the associated genomic or nongenomic molecular mechanisms. The experimental models from which data were collected were also considered. The review highlights ) in female ECs, transient receptor potential vanilloid 4 (TRPV4) and mitochondrial Ca uniporter (MCU) enhance Ca-dependent nitric oxide (NO) generation. In males, only transient receptor potential canonical 3 (TRPC3) plays a fundamental role in this effect. ) Female VSMCs have lower cytosolic Ca levels than males due to differences in the activity and expression of stromal interaction molecule 1 (STIM1), calcium release-activated calcium modulator 1 (Orai1), calcium voltage-gated channel subunit-α (Ca1.2), Na-K-2Cl symporter (NKCC1), and the Na/K-ATPase. ) When compared with androgens, the influence of estrogens on Ca homeostasis, vascular tone, and incidence of vascular disease is better documented. ) Many studies use supraphysiological concentrations of sex hormones, which may limit the physiological relevance of outcomes. ) Sex-dependent differences in Ca signaling mean both sexes ought to be included in experimental design.